Kết quả bước đầu của điều trị tân bổ trợ toàn diện trước phẫu thuật ở bệnh nhân ung thư trực tràng giai đoạn II, III tại Bệnh viện Trung ương Quân đội 108

To evaluate the early results of total neoadjuvant therapy (TNT) pre-operative in stage II, III rectal cancer patient at 108 Military Central Hospital and commented on some of the side effects and toxicity of this treatment. Subject and method: A descriptive retrospective study in 35 patients with stage II and III rectal cancer who received radiation therapy dose of 50.4Gy in combination with Capecitabine at the dose of 835mg/m2 × 2 times/day on the days of radiation therapy, then added neoadjuvant chemotherapy and followed surgery with total mesorectal excision 6-8 weeks later. Result: After TNT, there was 74.3% reduction in tumor stage and 93.4% reduction in lymph node stage, 100% of patients responded on pathology in which the completie response pathology (pCR) rate was 73.4%; Overall sphincter prevention rate reached 74.3%, with low rectal cancer reached 46.7%. Side effects were mainly at grade 1, 2. Conclusion: Total neoadjuvant therapy resulted in high rates of tumor and lymph node downstaging and sphincter preventation with acceptable side effects.